MARLTON, N.J. -- Cheap prescriptions from Canada are becoming a big business, with estimates placing its value as high as $650 million, but last month GlaxoSmithKline here launched an initiative to staunch the flow. The drug maker implemented a plan to halt the supply of prescription drugs to Canadian pharmacies that export to the United States. This latest development is another attempt to stop the revenue bleeding at U.S. retail pharmacies like supermarkets. U.S. pharmacies, including ...
REGISTER TO VIEW THIS ARTICLE - Register for a Free Account
Why Register for FREE?
Registering for content on Supermarket News will give you INSTANT access to invaluable articles and media content that industry professionals rely on. You will have access to our special reports, feature articles, and industry analysis. It’s FREE, easy and quick. What are you waiting for! In addition you will also receive a complimentary copy of SN's salary survey sent to you by email.
Attention Paid Print Subscribers: While you have already been granted free access to SN we ask that you register now. We promise it will only take a few minutes! Or visit your profile and add your print magazine account number and zip code.